BARBAS III CARLOS F has a total of 14 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SUZHOU ALPHAMAB CO LTD, CHUGAI SEJYAKU KK and INST RES BIOMEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Analysing materials | |
#6 | Heterocyclic compounds | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Measuring microorganism processes | |
#9 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Barbas Iii Carlos F | 14 |
#2 | Gavrilyuk Julia | 1 |
#3 | Beerli Roger | 1 |
#4 | Guo Jing | 1 |
#5 | Dreier Birgit | 1 |
#6 | Ban Hitoshi | 1 |
#7 | Gordley Russell M | 1 |
#8 | Kadan Michael Joseph | 1 |
Publication | Filing date | Title |
---|---|---|
US2014127200A1 | Multispecific Antibody Targeting and Multivalency Through Modular Recognition Domains | |
US2012020967A1 | VEGF antibodies comprising modular recognition domains | |
US2012020966A1 | Multispecific antibody targeting and multivalency through modular recognition domains | |
US2012034211A1 | EFGR antibodies comprising modular recognition domains | |
US2012058114A1 | ERBB2 antibodies comprising modular recognition domains | |
US2012329067A1 | Methods of Generating Zinc Finger Nucleases Having Altered Activity |